BACE1 and Alzheimer disease: In addition, the study conducted by Liu and colleagues also demonstrated that silencing of BACE1AS leads to an inability by BACE1 to cleave APP within neuroblastoma tumour-AD cell line models, therefore thwarting the aggravated development of senile plaques [97].